Storia della carriera di Al Boyle
Precedenti posizioni note di Al Boyle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2015 | 01/04/2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2009 | 01/11/2015 |
Formazione di Al Boyle
| SUNY College of Environmental Science | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Al Boyle
- Esperienza
